Harmine C-11
Internal ID | 2e6ac2e0-aefd-4552-96e5-e667c385453f |
Taxonomy | Alkaloids and derivatives > Harmala alkaloids |
IUPAC Name | 7-(111C)methoxy-1-methyl-9H-pyrido[3,4-b]indole |
SMILES (Canonical) | CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC |
SMILES (Isomeric) | CC1=NC=CC2=C1NC3=C2C=CC(=C3)O[11CH3] |
InChI | InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3/i2-1 |
InChI Key | BXNJHAXVSOCGBA-JVVVGQRLSA-N |
Popularity | 0 references in papers |
Molecular Formula | C13H12N2O |
Molecular Weight | 211.25 g/mol |
Exact Mass | 211.1063956 g/mol |
Topological Polar Surface Area (TPSA) | 37.90 Ų |
XlogP | 3.60 |
Atomic LogP (AlogP) | 3.03 |
H-Bond Acceptor | 2 |
H-Bond Donor | 1 |
Rotatable Bonds | 1 |
C06QCS6OX3 |
UNII-C06QCS6OX3 |
9H-Pyrido(3,4-b)indole, 7-(methoxy-11C)-1-methyl- |
171882-19-2 |
[11C]Harmine |
[11C]HAR |
MOLI001537 |
7-[Methoxy-11C]methyl-9H-[3,4-b]indole |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 1.0000 | 100.00% |
Caco-2 | - | 0.9373 | 93.73% |
Blood Brain Barrier | + | 0.7879 | 78.79% |
Human oral bioavailability | + | 0.6429 | 64.29% |
Subcellular localzation | Mitochondria | 0.8289 | 82.89% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.9545 | 95.45% |
OATP1B3 inhibitior | + | 0.9509 | 95.09% |
MATE1 inhibitior | - | 0.9200 | 92.00% |
OCT2 inhibitior | - | 0.8000 | 80.00% |
BSEP inhibitior | + | 0.5524 | 55.24% |
P-glycoprotein inhibitior | - | 0.9379 | 93.79% |
P-glycoprotein substrate | - | 0.6866 | 68.66% |
CYP3A4 substrate | - | 0.5228 | 52.28% |
CYP2C9 substrate | - | 0.7825 | 78.25% |
CYP2D6 substrate | - | 0.6664 | 66.64% |
CYP3A4 inhibition | + | 0.6929 | 69.29% |
CYP2C9 inhibition | - | 0.9481 | 94.81% |
CYP2C19 inhibition | - | 0.9026 | 90.26% |
CYP2D6 inhibition | + | 0.8932 | 89.32% |
CYP1A2 inhibition | + | 0.9629 | 96.29% |
CYP2C8 inhibition | + | 0.5260 | 52.60% |
CYP inhibitory promiscuity | + | 0.6307 | 63.07% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.9823 | 98.23% |
Carcinogenicity (trinary) | Non-required | 0.4942 | 49.42% |
Eye corrosion | - | 0.9899 | 98.99% |
Eye irritation | + | 0.7751 | 77.51% |
Skin irritation | - | 0.8323 | 83.23% |
Skin corrosion | - | 0.9609 | 96.09% |
Ames mutagenesis | + | 0.8800 | 88.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.4124 | 41.24% |
Micronuclear | + | 0.8000 | 80.00% |
Hepatotoxicity | + | 0.5638 | 56.38% |
skin sensitisation | - | 0.9251 | 92.51% |
Respiratory toxicity | - | 0.6111 | 61.11% |
Reproductive toxicity | + | 0.6889 | 68.89% |
Mitochondrial toxicity | - | 0.7000 | 70.00% |
Nephrotoxicity | - | 0.8725 | 87.25% |
Acute Oral Toxicity (c) | III | 0.6254 | 62.54% |
Estrogen receptor binding | + | 0.8701 | 87.01% |
Androgen receptor binding | + | 0.8462 | 84.62% |
Thyroid receptor binding | + | 0.7327 | 73.27% |
Glucocorticoid receptor binding | + | 0.8713 | 87.13% |
Aromatase binding | + | 0.8812 | 88.12% |
PPAR gamma | + | 0.5826 | 58.26% |
Honey bee toxicity | - | 0.9541 | 95.41% |
Biodegradation | - | 0.9250 | 92.50% |
Crustacea aquatic toxicity | + | 0.8100 | 81.00% |
Fish aquatic toxicity | - | 0.7539 | 75.39% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL2111389 | O60563 | CDK9/cyclin T1 |
720 nM |
IC50 |
via Super-PRED
|
CHEMBL5543 | Q9Y463 | Dual specificity tyrosine-phosphorylation-regulated kinase 1B |
28 nM |
IC50 |
via Super-PRED
|
CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 |
26 nM |
IC50 |
via Super-PRED
|
CHEMBL2292 | Q13627 | Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
8.81 nM |
IC50 |
via Super-PRED
|
CHEMBL4376 | Q92630 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 |
120 nM |
IC50 |
via Super-PRED
|
CHEMBL4575 | O43781 | Dual-specificity tyrosine-phosphorylation regulated kinase 3 |
210 nM |
IC50 |
via Super-PRED
|
CHEMBL1951 | P21397 | Monoamine oxidase A |
5 nM |
Ki |
via Super-PRED
|
CHEMBL3923 | Q9Y2I1 | Nischarin |
22 nM |
Ki |
via Super-PRED
|
CHEMBL1075163 | Q8TF76 | Serine/threonine-protein kinase haspin |
590 nM |
IC50 |
via Super-PRED
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 93.48% | 94.00% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 93.36% | 96.09% |
CHEMBL1907 | P15144 | Aminopeptidase N | 92.95% | 93.31% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 92.31% | 95.56% |
CHEMBL1868 | P17948 | Vascular endothelial growth factor receptor 1 | 92.12% | 96.47% |
CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 91.33% | 93.99% |
CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 90.05% | 94.80% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 88.65% | 94.45% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 86.80% | 91.11% |
CHEMBL3714130 | P46095 | G-protein coupled receptor 6 | 86.61% | 97.36% |
CHEMBL4208 | P20618 | Proteasome component C5 | 85.60% | 90.00% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 84.73% | 96.00% |
CHEMBL2424504 | P29375 | Lysine-specific demethylase 5A | 83.90% | 99.23% |
CHEMBL4145 | Q9UKV0 | Histone deacetylase 9 | 83.82% | 85.49% |
CHEMBL255 | P29275 | Adenosine A2b receptor | 83.77% | 98.59% |
CHEMBL1781 | P11387 | DNA topoisomerase I | 83.64% | 97.00% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 83.52% | 99.15% |
CHEMBL2095172 | P14867 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 83.46% | 92.67% |
CHEMBL2535 | P11166 | Glucose transporter | 82.96% | 98.75% |
CHEMBL2146302 | O94925 | Glutaminase kidney isoform, mitochondrial | 82.63% | 100.00% |
CHEMBL5409 | Q8TDU6 | G-protein coupled bile acid receptor 1 | 82.41% | 93.65% |
CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 82.15% | 100.00% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 82.07% | 94.75% |
CHEMBL4016 | P42262 | Glutamate receptor ionotropic, AMPA 2 | 80.77% | 86.92% |
CHEMBL2378 | P30307 | Dual specificity phosphatase Cdc25C | 80.57% | 96.67% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Elaeagnus angustifolia |
Hippophae rhamnoides |
Passiflora edulis |
Passiflora incarnata |
Peganum harmala |
Polygala tenuifolia |
Tribulus terrestris |
Uncaria rhynchophylla |